
BenchSci Expands Board of Directors with Appointment of Dr. Mikael Dolsten
BenchSci, a world leader in AI solutions for preclinical research and drug discovery, today announced that Mikael Dolsten, M.D., Ph.D., has joined its board of directors. Dr. Dolsten, recently retired from Pfizer Inc., brings over three decades of extensive leadership and…












